19 June 2013
Keywords: ziopharm, gets, eu, orphan, nod, palifosfamide, usa-based
Article | 27 October 2008
USA-based Ziopharm Oncology says that the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) has issued a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 November 2008
23 March 2009
19 May 2008
© 2013 thepharmaletter.com